Lista de obras -

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

article

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

article by L. Samuel Wann et al published January 2011 in Journal of the American College of Cardiology

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

artículo científico publicado en 2010

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

artículo científico publicado en 2010

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

artículo científico publicado en 2011

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

article

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

artículo científico publicado en 2013

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

artículo científico publicado en 2010

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

artículo científico publicado en 2006

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

article by Valentin Fuster et al published August 2006 in Journal of the American College of Cardiology

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

artículo científico publicado en 2007

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

artículo científico publicado en 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

scientific article published on 01 September 2006

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiolog

artículo científico publicado en 2007

Abnormalities of ventricular repolarization in mitral valve prolapse.

artículo científico publicado en 2005

Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

scientific article published on 21 September 2020

Atrial fibrillation and anticoagulation: general practitioner, cardiologist and patient's points of view

artículo científico publicado en 2013

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

artículo científico publicado en 2005

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

artículo científico publicado en 2013

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

artículo científico publicado en 2015

Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.

artículo científico publicado en 2016

Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation

artículo científico publicado en 2012

Chronic cor pulmonale: a rare complication of undiagnosed pacemaker lead endocarditis

artículo científico publicado en 2004

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey

artículo científico publicado en 2012

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study

artículo científico publicado en 2014

Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]

scholarly article published in European Heart Journal

Cost analysis of catheter ablation for paroxysmal atrial fibrillation

scientific article published on 01 January 2003

Cost of care distribution in atrial fibrillation patients: the COCAF study

artículo científico publicado en 2004

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis

scientific article published on 01 November 2019

Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.

artículo científico publicado en 2018

Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry

artículo científico publicado en 2014

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial

artículo científico publicado en 2017

Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of French hospitalization data

artículo científico publicado en 2011

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

artículo científico publicado en 2015

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

artículo científico

Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies

scientific article published on 05 June 2020

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

artículo científico publicado en 2014

GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke

artículo científico publicado en 2020

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

artículo científico publicado en 2010

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

artículo científico publicado en 2010

Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillatio

artículo científico publicado en 2014

Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort

scientific article published on 01 December 2011

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.

artículo científico publicado en 2017

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)

artículo científico publicado en 2013

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

artículo científico publicado en 2013

Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach

artículo científico publicado en 2012

Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.

artículo científico publicado en 2015

Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.

artículo científico publicado en 2017

Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).

artículo científico publicado en 2013

Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system

artículo científico publicado en 2008

Performance assessment of a chest pain unit: Preliminary 2-year experience in the European Georges Pompidou Hospital

artículo científico publicado en 2009

Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey

artículo científico publicado en 2010

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation

artículo científico publicado en 2008

Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy

artículo científico publicado en 2012

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

artículo científico publicado en 2017

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers

artículo científico publicado en 2012

Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxab

artículo científico publicado en 2014

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

artículo científico publicado en 2011

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator

artículo científico publicado en 2008

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

artículo científico publicado en 2014

Rhythm control versus rate control for atrial fibrillation and heart failure

artículo científico publicado en 2008

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

artículo científico publicado en 2014

SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study

artículo científico publicado en 2014

Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial

scientific article published on 22 November 2018

Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions

artículo científico publicado en 2014

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

artículo científico publicado en 2013

The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation

artículo científico publicado en 2009

The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey

artículo científico publicado en 2017

Treatment of atrial fibrillation in heart failure

artículo científico publicado en 2009

Understanding the atrioventricular dissociation

scientific article published on 11 May 2012

[Atrial fibrillation: the most common arrhythmia]

artículo científico publicado en 2008

[Cardiac arrhythmias in the elderly]

artículo científico publicado en 2006

[Catheter cryoablation for the treatment of supraventricular arrhythmias]

scientific article published on 01 January 2004

[Guidelines for cardiac pacing and cardiac resynchronization therapy]

scientific article published on 01 May 2008

[Guidelines for the management of patients with atrial fibrillation. Executive summary]

artículo científico publicado en 2006

[Guidelines in cardiac pacing and resynchronization therapy].

artículo científico publicado en 2007

Lista de obras de

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiolog

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committ

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiolog

Abnormalities of ventricular repolarization in mitral valve prolapse.

Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012

Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

Atrial fibrillation and anticoagulation: general practitioner, cardiologist and patient's points of view

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation

Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study

Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.

Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.

Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation

Chronic cor pulmonale: a rare complication of undiagnosed pacemaker lead endocarditis

Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study

Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]

Cost analysis of catheter ablation for paroxysmal atrial fibrillation

Cost of care distribution in atrial fibrillation patients: the COCAF study

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis

Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention.

Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial

Epidemiology of atrial fibrillation in France: extrapolation of international epidemiological data to France and analysis of French hospitalization data

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillatio

Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Management of ventricular and atrial arrhythmias in humans: towards a patient-specific approach

Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.

Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF.

Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).

Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system

Performance assessment of a chest pain unit: Preliminary 2-year experience in the European Georges Pompidou Hospital

Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey

Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation

Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy

Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers

Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxab

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator

Response to letter regarding article, "Causes of death and influencing factors in patients with atrial fibrillation: a competing-risk analysis from the randomized evaluation of long-term anticoagulant therapy study"

Rhythm control versus rate control for atrial fibrillation and heart failure

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation

SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study

Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial

Stroke Prevention in Atrial Fibrillation - Outcomes and Future Directions

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation

The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey

Treatment of atrial fibrillation in heart failure

Understanding the atrioventricular dissociation

[Atrial fibrillation: the most common arrhythmia]

[Cardiac arrhythmias in the elderly]

[Catheter cryoablation for the treatment of supraventricular arrhythmias]

[Guidelines for cardiac pacing and cardiac resynchronization therapy]

[Guidelines for the management of patients with atrial fibrillation. Executive summary]

[Guidelines in cardiac pacing and resynchronization therapy].